CIBC Global Asset Management »

Aclaris Therapeutics shares owned by CIBC Global Asset Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by CIBC Global Asset Management from 13F filings

Historical chart of CIBC Global Asset Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by CIBC Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by CIBC Global Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $53k 17k 3.01

More positions owned by CIBC Global Asset Management

Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Cibc Cad (CM)
Barrick Mng Corp Com Shs (B)
Amazon (AMZN)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Bk Nova Cad (BNS)
Shopify Cl A Sub Vtg Shs (SHOP)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)

View all positions for CIBC Global Asset Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Vivo Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Rock Springs Capital Management
Decheng Capital
Geode Capital Management
D. E. Shaw & Co
Acadian Asset Management
Palo Alto Investors
Millennium Management
State Street Corporation
Connor, Clark & Lunn Investment Management
Citadel Advisors

View all funds holding Aclaris Therapeutics